OS Therapies Inc. Completes Acquisition, Reports Equity Sales
Ticker: OSTX · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1795091
| Field | Detail |
|---|---|
| Company | Os Therapies Inc (OSTX) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, equity-sale, corporate-action
TL;DR
OS Therapies closed a deal and sold some stock.
AI Summary
On April 9, 2025, OS Therapies Inc. reported the completion of an acquisition. The filing also disclosed unregistered sales of equity securities and other events, along with financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Grasonville, Maryland.
Why It Matters
This filing indicates significant corporate activity for OS Therapies Inc., including an acquisition and equity sales, which could impact its financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing details an acquisition and unregistered equity sales, which can introduce financial and operational risks.
Key Players & Entities
- OS Therapies Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Grasonville, Maryland (location) — Principal Executive Offices
- April 9, 2025 (date) — Date of earliest event reported
FAQ
What was the nature of the acquisition completed by OS Therapies Inc. on April 9, 2025?
The filing states that OS Therapies Inc. completed an acquisition or disposition of assets on April 9, 2025, but does not provide specific details about the nature of the transaction.
What type of equity securities were sold by OS Therapies Inc.?
The filing mentions 'Unregistered Sales of Equity Securities' but does not specify the type or amount of securities sold.
Where are the principal executive offices of OS Therapies Inc. located?
The principal executive offices of OS Therapies Inc. are located at 115 Pullman Crossing Road, Suite 103, Grasonville, Maryland 21638.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for OS Therapies Inc.?
The Standard Industrial Classification (SIC) code for OS Therapies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding OS Therapies Inc (OSTX).